虚弱对子宫内膜癌术后再入院、并发症和死亡率的影响
该研究利用2010至2014年全国再入院数据库,纳入144,809例子宫内膜癌子宫切除术患者,其中虚弱率为1.8%。虚弱与指数住院期间 intens 监护、非 routine 出院和住院死亡率升高相关,也增加30天和90天再入院风险及30天再入院期间死亡率,且住院费用更高。
要点
- 虚弱患者指数住院期间 intens 监护风险增加(aRR=3.61,95%CI 2.95-4.42)。
- 虚弱增加30天(RR 1.33)和90天(RR 1.21)再入院风险。
- 30天再入院期间死亡风险升高(aRR=1.75,95%CI 1.28-2.39)。
核心结论
- 虚弱影响子宫内膜癌患者术后结局,与再入院率及再入院后30天死亡率升高相关。
研究设计与样本
- 基于全国再入院数据库的回顾性队列研究,纳入2010至2014年144,809例子宫内膜癌子宫切除术患者。
- 虚弱采用约翰霍普金斯调整临床组虚弱诊断指标分类。
主要发现
- 虚弱率为1.8%。
- 虚弱与指数住院期间 intens 监护(aRR=3.61,95%CI 2.95-4.42)、非 routine 出院(aRR=1.59,95%CI 1.51-1.68)和住院死亡率(aRR=2.05,95%CI 1.68-2.51)风险升高相关。
- 虚弱患者30天再入院(RR 1.33,95%CI 1.22-1.47)和90天再入院(RR 1.21,95%CI 1.12-1.32)风险更高,30天再入院期间死亡率升高(aRR=1.75,95%CI 1.28-2.39)。
- 虚弱与90天死亡率无关。
- 虚弱患者在指数住院及30天和90天再入院期间的住院费用显著更高(p < 0.05 for all)。
临床怎么用
- 妇科肿瘤医生应筛查虚弱,并在术前咨询中考虑虚弱患者的手术结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the impact of frailty on postoperative readmission, morbidity, and mortality among patients undergoing surgery for endometrial cancer. METHODS: Patients with endometrial cancer undergoing hysterectomy between 2010 and 2014 were identified using the Nationwide Readmissions Database. Frailty was classified using criteria outlined by the Johns Hopkins Adjusted Clinical Groups Frailty Diagnoses Indicators. Primary outcomes were divided by index surgical admission (intensive level of care, mortality, non-routine discharge), 30-days (readmission and mortality), and 90-days (readmission and mortality) after discharge. Multivariable log linear regression models were fit to analyze the effect of frailty on these outcomes, adjusting for patient, hospital, and clinical factors. RESULTS: From 2010 to 2014, there were 144,809 surgical endometrial cancer cases with a 1.8% frailty rate. Frailty was associated with an increased risk of intensive level of care (aRR = 3.61, 95% CI: 2.95, 4.42), non-routine discharge (aRR = 1.59, 95% CI: 1.51, 1.68), and inpatient mortality (aRR = 2.05, 95% CI: 1.68, 2.51) during index admission. Frail patients were more likely to be readmitted within 30 days (RR 1.33, 95% CI 1.22-1.47) and 90-days (RR 1.21, 95% CI 1.12, 1.32), and were at increased risk of mortality during their 30-day readmission (aRR = 1.75, 95% CI: 1.28-2.39). Frailty was not associated with 90-day mortality. Hospitalization costs for frail patients were significantly higher than for non-frail patients during index admission and readmissions within 30 and 90 days (p < 0.05 for all). CONCLUSIONS: Frailty affects postoperative outcomes in endometrial cancer patients and is associated with an increased rate of readmission and 30-day mortality among those who are readmitted. Gynecologic cancer providers should screen for frailty and consider outcomes in frail patients when counseling them for surgery.
引用
- Sia TY, Wen T, Cham S, et al. The effect of frailty on postoperative readmissions, morbidity, and mortality in endometrial cancer surgery. Gynecol Oncol. 2021. PMID: 33640158. doi:10.1016/j.ygyno.2021.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。